phase ii trial-in-progress of itacitinib in patients with myelofibrosis
Published 3 years ago • 45 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
8:03
phase ii trial of navitoclax and ruxolitinib in high-risk r/r myelofibrosis
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
3:02
update on phase ib trial of avid200 in myelofibrosis
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
1:39
phase i/ii trial of adct-602 in b-all
-
13:48
understanding treatment options for et, pv, and myelofibrosis
-
1:46
how would the approval of luspatercept benefit the treatment landscape in myelofibrosis
-
58:27
laboratory nonconformance (event) management
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
3:44
phase ii study update of navtemadlin in patients with myelofibrosis r/r to ruxolitinib
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:55
itacitinib in patients with acute gvhd
-
2:43
phase i/ii trial of tagraxofusp in poor-risk myelofibrosis
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
2:46
a phase ii trial of pembrolizumab for richter's transformation of cll
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies